Skip to main content
. 2014 Nov 30;56(5):405–409. doi: 10.3340/jkns.2014.56.5.405

Fig. 1.

Fig. 1

Pituitary MRI before and after treatment. A : Case 1. 28 yr, female, before surgery GH >40 µg/L, after surgery GH 0.40 µg/L. B : Case 2. 34 yr, male, Albright Syndrome, tumor was surrounded fibrous dysplasia of bone, before surgery GH >40 µg/L, after surgery GH 0.72 µg/L. C : Case 3. 16 yr, male, July 15, 2011, before craniotomy surgery, tumor located at suprasellar and intrasellar, extending to skull base, GH >40 µg/L; October 17, 2011, before trans-sphenoidal surgery, the residual tumor located at right intrasellar and pressed on right cavernous sinus, GH >40 µg/L; follow-up in 2013, no residual tumor supersellar and intrasellar, GH >40 µg/L. Then after treatment with long acting SSA for one year, the patient showed normal GH and improved symptoms including headache. GH : growth hormone, SSA : somatostatin analogue.